formation ğ‘ğ‘› ğ‘,ğ‘‘, relative to a claim ğ‘, as follows: ğ‘‰ (ğ‘, ğ‘‘) = ğ‘ğ‘Ÿğ‘”ğ‘šğ‘ğ‘¥ (ğ‘ğ‘Ÿ ğ‘,ğ‘‘, ğ‘ğ‘› ğ‘,ğ‘‘, ğ‘ğ‘  ğ‘,ğ‘‘ ) (2) +Verification (Ideal Reranker Model) combines semantic relevance and verification feedback to refine evidential retrieval. The final retrieval score is calculated by summing the semantic score (ğ‘ ğ‘Ÿ ğ‘,ğ‘‘) and the verification probabilities (ğ‘ğ‘Ÿ ğ‘,ğ‘‘ and ğ‘ğ‘› ğ‘,ğ‘‘), followed by a nor- malisation step to ensure the score remains within (0,1), formulated as: ğ‘ ğ‘Ÿ +ğ‘£ ğ‘,ğ‘‘ = 1/2 âˆ— (ğ‘ ğ‘Ÿ ğ‘,ğ‘‘ + ğ‘ğ‘Ÿ ğ‘,ğ‘‘ + ğ‘ğ‘  ğ‘,ğ‘‘ ) âˆˆ ( 0, 1) (3) This formulation ensures that documents contributing to support or refute labels receive higher retrieval scores, enhancing the evi- dential quality of retrieved documents. To evaluate retrieval effectiveness, we use Recall@k (R@k), a common evaluation approach that measures the proportion of rele- vant evidence successfully retrieved within the top ğ‘˜ results. 1https://github.com/dwadden/multivers Table 1: Retrieval result on SciFact-Open and Check-COVID SciFact-Open R@50 R@20 R@10 R@5 R@3 R@1 BM25 66.09 54.78 45.22 38.04 30.87 20.22 monoT5-3B 88.91 79.13 71.09 57.17 48.26 31.09 +Verification 91.96 81.95 71.30 62.61 52.83 32.17 Check-COVID R@50 R@20 R@10 R@5 R@3 R@1 BM25 87.91 81.96 75.02 67.59 61.35 46.18 monoT5-3B 95.84 93.16 89.49 82.06 74.93 58.28 +Verification 96.13 94.55 91.48 84.04 77.80 61.84 Table 2: Evidence positions in the retrieved list. We select an ex- ample from the SciFact-Open dataset. Claim: Female carriers of the Apolipoprotein E4 (APOE4) allele have a reduced risk for Alzheimerâ€™s disease. Gold Evidence: [E1,E2,E3,E4,E5] reranker model E1 E2 E3 E4 E5 BM25 838th 141th 7th 163th 67th monot5-3B 1st 8th 16th 2nd 302nd +Verification 1st 3rd 5th 2nd 27th Datasets. We conduct our evaluation using datasets including: (1) SciFact [100]: A corpus of 5,183 abstracts from scientific arti- cles, with 809/300/300 samples for train, validation and test sets. The